ANN SHATTUCK: Open Payments
NPI 1417566936 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,345 in 136 payments from 40 companies in 2025. Trend: 2023 $2,998 · 2024 $2,773 · 2025 $3,345
Food & beverage: $3,245Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $259 |
| Daiichi Sankyo Inc. | 10 | $235 |
| Celgene Corporation | 11 | $220 |
| Kite Pharma, Inc. | 4 | $211 |
| E.R. Squibb & Sons, L.L.C. | 10 | $192 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| Novocure Inc. | 2 | $135 |
| JAZZ PHARMACEUTICALS INC. | 5 | $130 |
| Incyte Corporation | 2 | $126 |
| Janssen Biotech, Inc. | 4 | $121 |
Products named: Yescarta, REBLOZYL, DATROWAY, OPDIVO, Optune Lua (NovoTTF-200T), ZEPZELCA, KEYTRUDA, SCEMBLIX.
Industry payments across SC — which companies pay providers there.
